I am a partner at Gibbs Law Group LLP and Of Counsel to Girard Gibbs LLP, and I represent clients in a wide variety of medical mass tort matters, including In re: Pelvic Repair System Products Liability Litigation; In re: Yasmin and Yaz (Drospirenone) Marketing, Sales Practices and Products Liability Litigation; In re: Actos (Pioglitazone) Products Liability Litigation; In re: Risperdal and Invega Product Liability Cases JCCP 4775; and In re: Mirena IUD Products Liability Litigation, among others.
I also represent consumers in class action litigation, and have experience working closely with class representatives and consumer contacts and participating in all stages of litigation. I have been involved in successful actions against Chase Bank, Ducati, and Dish Network. I am currently speaking with clients and investigating claims about the effects of Syngenta’s GMO corn seed on U.S. corn export prices in In re: Syngenta AG MIR 162 Corn Litigation.
I am admitted to the California Bar and the Florida Bar.
|FL||Member in Good Standing||2014||12/17/2019|
|Award name||Grantor||Date granted|
|Partner||Gibbs Law Group LLP||2014 - Present|
|Association name||Position name||Duration|
|American Bar Association||Member||2010 - Present|
|American Association for Justice||Member||2010 - Present|
|American Association for Justice, Women Trial Lawyers Caucus, Connections Count newsletter||Tips on Client Contact and Case Management in Mass Torts Part I: Client Intake and Gathering Relevant Information (Co-authored with Claire Y. Choo)||2013|
|American Association for Justice, Women Trial Lawyers Caucus, Connections Count newsletter||Tips on Client Contact and Case Management in Mass Torts Part II: Organizing and Working with Client Information||2013|
|University of California, Hastings College of The Law||J.D.||2010|
|University of Missouri||B.A.||1998|
|In re Chase Bank USA, N.A. “Check Loan” Contract Litigation||On November 19, 2012, U.S. District Judge Maxine M. Chesney granted final approval of a $100 million settlement with JPMorgan Chase & Co. on behalf of Chase cardholders.|
|In Re Yasmin and Yaz (Drospirenone) Marketing, Sales Practices, and Product Liability Litigation||Bayer Healthcare Pharmaceuticals, makers of Yasmin and Yaz, have paid out $1.7 billion thus far to women alleging thrombotic and gallbladder injuries resulting from the use of their birth control pills.|
|In re: Actos (Pioglitazone) Products Liability Litigation||Amy Zeman and other counsel for plaintiffs nationwide are currently in settlement talks with Takeda Pharmaceutical Company, manufacturer of Actos.|
|In re: Pelvic Repair System Products Liability Litigation||Amy Zeman and other counsel for plaintiffs nationwide are currently in settlement talks with Johnson & Johnson, C.R. Bard, American Medical Systems, and Boston Scientific, all manufacturers of transvaginal mesh implants.|
|In re: Risperdal and Invega Product Liability Cases JCCP 4775||Risperdal and Invega lawsuits filed nationwide have been coordinated in California into JCCP 4775. In addition to working directly with clients, Amy provides support to Gibbs Law Group colleague Eric Gibbs, who serves as Co-Liaison Counsel in the JCCP.|